Surfactant Delivery Methods for Premature Babies with Breathing Problems
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born before 37 weeks of pregnancy (premature)
- Baby received surfactant medication within the first 48 hours after birth
- Baby has been diagnosed with or suspected to have respiratory distress syndrome (RDS)—a common breathing problem in premature infants
- Baby actually received surfactant treatment by any method
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving surfactant (a natural substance that helps lungs stay open) to premature babies who need extra breathing support. It aims to find which method works better and is safer for infants born at 29 to 36 weeks.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This trial compares two types of surfactant (Calfactant and Poractant Alfa) given through a less invasive method to very premature babies with breathing problems. It aims to see if one works better at helping them breathe without needing a breathing tube.
This study compares two methods—video laryngoscopy and direct laryngoscopy—to give surfactant (a medicine that helps babies' lungs work better) to very premature infants. It aims to find which method is safer and easier for babies born at 28 weeks or earlier who need surfactant within the first 36 hours after birth.
This trial tests if giving surfactant (a natural substance that helps lungs stay open) through a special airway device can help late preterm and early term infants with breathing problems. The goal is to see if this approach works better than current methods without needing a breathing tube.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
Hear when a new Respiratory Distress Syndrome (Neonatal) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.